Prevalence and risk factors of detectable HIV viral load among pregnant women with HIV infection seeking antenatal care in Southern Malawi.

HIV infection HIV suppression Malawi SDG 3: good health and well-being adherence pregnancy

Journal

AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313

Informations de publication

Date de publication:
07 Jan 2024
Historique:
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 7 1 2024
Statut: aheadofprint

Résumé

We evaluated detectable viral load (VL) in pregnant women established on antiretroviral therapy (ART) for at least 6 months before conception and those self-reported as ART naïve at first antenatal care (ANC) at two government clinics in Southern Malawi. We used logistic regression to identify the predictors of detectable viral load (VL), defined as any measure greater than 400 copies/ml. Of 816 women, 67.9% were established on ART and 32.1% self-reported as ART naïve. Among women established on ART, 10.8% had detectable VL and 9.9% had VL >1000 copies/ml (WHO criteria for virological failure). In adjusted analysis, among women established on ART, virological failure was associated with younger age (

Identifiants

pubmed: 38184889
doi: 10.1080/09540121.2023.2298792
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Felix A Mkandawire (FA)

Blantyre Malaria Project, Kamuzu University of Health Sciences, College of Medicine, Blantyre, Malawi.
Amref International University, Nairobi, Kenya.

Andrea Buchwald (A)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Nginache Nampota-Nkomba (N)

Blantyre Malaria Project, Kamuzu University of Health Sciences, College of Medicine, Blantyre, Malawi.

Osward M Nyirenda (OM)

Blantyre Malaria Project, Kamuzu University of Health Sciences, College of Medicine, Blantyre, Malawi.

Kingsley Zuze (K)

Blantyre Malaria Project, Kamuzu University of Health Sciences, College of Medicine, Blantyre, Malawi.

Shiphrah Kuria (S)

Amref International University, Nairobi, Kenya.

Cristiana Cairo (C)

Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.

Miriam K Laufer (MK)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Classifications MeSH